Logo image of CLR

CONTINENTAL RESOURCES INC/OK (CLR) Stock Fundamental Analysis

NYSE:CLR - New York Stock Exchange, Inc. - US2120151012 - Common Stock - Currency: USD

74.27  +0.03 (+0.04%)

After market: 74.27 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLR. CLR was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLR have multiple concerns. CLR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLR was profitable.
In the past year CLR had a positive cash flow from operations.
CLR Yearly Net Income VS EBIT VS OCF VS FCFCLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B 3B

1.2 Ratios

Industry RankSector Rank
ROA 15.9%
ROE 35.86%
ROIC 20.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLR Yearly ROA, ROE, ROICCLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20

1.3 Margins

CLR's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of CLR has grown nicely.
Industry RankSector Rank
OM 57.57%
PM (TTM) 40.3%
GM N/A
OM growth 3Y6.67%
OM growth 5YN/A
PM growth 3Y11.44%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLR Yearly Profit, Operating, Gross MarginsCLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLR is still creating some value.
The number of shares outstanding for CLR remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CLR has an improved debt to assets ratio.
CLR Yearly Shares OutstandingCLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
CLR Yearly Total Debt VS Total AssetsCLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 5B 10B 15B

2.2 Solvency

CLR has an Altman-Z score of 3.01. This indicates that CLR is financially healthy and has little risk of bankruptcy at the moment.
CLR has a debt to FCF ratio of 21.50. This is a negative value and a sign of low solvency as CLR would need 21.50 years to pay back of all of its debts.
CLR has a Debt/Equity ratio of 0.57. This is a neutral value indicating CLR is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 21.5
Altman-Z 3.01
ROIC/WACC1.64
WACC12.41%
CLR Yearly LT Debt VS Equity VS FCFCLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 2B 4B 6B

2.3 Liquidity

CLR has a Current Ratio of 1.20. This is a normal value and indicates that CLR is financially healthy and should not expect problems in meeting its short term obligations.
CLR has a Quick Ratio of 1.15. This is a normal value and indicates that CLR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.15
CLR Yearly Current Assets VS Current LiabilitesCLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

CLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 307.17%, which is quite impressive.
CLR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.89% yearly.
The Revenue has grown by 90.95% in the past year. This is a very strong growth!
The Revenue has been growing by 23.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)307.17%
EPS 3Y17.89%
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)90.95%
Revenue growth 3Y6.69%
Revenue growth 5Y23.63%
Sales Q2Q%82.44%

3.2 Future

CLR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.16% yearly.
CLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.37% yearly.
EPS Next Y161.62%
EPS Next 2Y53.57%
EPS Next 3Y26.47%
EPS Next 5Y9.16%
Revenue Next Year73.48%
Revenue Next 2Y32.17%
Revenue Next 3Y16.44%
Revenue Next 5Y7.37%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLR Yearly Revenue VS EstimatesCLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CLR Yearly EPS VS EstimatesCLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.88, which indicates a rather cheap valuation of CLR.
CLR is valuated cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
CLR is valuated cheaply with a Price/Forward Earnings ratio of 6.74.
When comparing the Price/Forward Earnings ratio of CLR to the average of the S&P500 Index (21.94), we can say CLR is valued rather cheaply.
Industry RankSector Rank
PE 6.88
Fwd PE 6.74
CLR Price Earnings VS Forward Price EarningsCLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 90.61
EV/EBITDA 4.48
CLR Per share dataCLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLR's earnings are expected to grow with 26.47% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y53.57%
EPS Next 3Y26.47%

More info and screens

2

5. Dividend

5.1 Amount

CLR has a Yearly Dividend Yield of 1.51%. Purely for dividend investing, there may be better candidates out there.
CLR's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

CLR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CLR Yearly Dividends per shareCLR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 0.2 0.4 0.6

5.3 Sustainability

9.98% of the earnings are spent on dividend by CLR. This is a low number and sustainable payout ratio.
DP9.98%
EPS Next 2Y53.57%
EPS Next 3Y26.47%
CLR Yearly Income VS Free CF VS DividendCLR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 500M -500M 1B -1B 1.5B
CLR Dividend Payout.CLR Dividend Payout, showing the Payout Ratio.CLR Dividend Payout.PayoutRetained Earnings

More info and screens

CONTINENTAL RESOURCES INC/OK

NYSE:CLR (11/22/2022, 8:04:00 PM)

After market: 74.27 0 (0%)

74.27

+0.03 (+0.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-02 2022-11-02/amc
Earnings (Next)02-13 2023-02-13
Inst Owners0.03%
Inst Owner Change0%
Ins Owners43.92%
Ins Owner Change0%
Market Cap26.56B
Analysts55.2
Price Target76.44 (2.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.79
Dividend Growth(5Y)N/A
DP9.98%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.77%
Min EPS beat(2)-2.73%
Max EPS beat(2)8.27%
EPS beat(4)3
Avg EPS beat(4)5.25%
Min EPS beat(4)-2.73%
Max EPS beat(4)10.91%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.24%
Min Revenue beat(2)-2.89%
Max Revenue beat(2)2.41%
Revenue beat(4)2
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-13.88%
Max Revenue beat(4)11.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-0.84%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.87%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.88
Fwd PE 6.74
P/S 3
P/FCF 90.61
P/OCF 3.96
P/B 2.67
P/tB 2.71
EV/EBITDA 4.48
EPS(TTM)10.79
EY14.53%
EPS(NY)11.01
Fwd EY14.83%
FCF(TTM)0.82
FCFY1.1%
OCF(TTM)18.76
OCFY25.26%
SpS24.72
BVpS27.78
TBVpS27.37
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.9%
ROE 35.86%
ROCE N/A
ROIC 20.31%
ROICexc 22.44%
ROICexgc 22.44%
OM 57.57%
PM (TTM) 40.3%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y5.57%
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y6.67%
OM growth 5YN/A
PM growth 3Y11.44%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 21.5
Debt/EBITDA N/A
Cap/Depr 348.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 8.23%
Current Ratio 1.2
Quick Ratio 1.15
Altman-Z 3.01
F-Score7
WACC12.41%
ROIC/WACC1.64
Cap/Depr(3y)162.02%
Cap/Depr(5y)151.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)307.17%
EPS 3Y17.89%
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y161.62%
EPS Next 2Y53.57%
EPS Next 3Y26.47%
EPS Next 5Y9.16%
Revenue 1Y (TTM)90.95%
Revenue growth 3Y6.69%
Revenue growth 5Y23.63%
Sales Q2Q%82.44%
Revenue Next Year73.48%
Revenue Next 2Y32.17%
Revenue Next 3Y16.44%
Revenue Next 5Y7.37%
EBIT growth 1Y263.64%
EBIT growth 3Y13.8%
EBIT growth 5YN/A
EBIT Next Year237.16%
EBIT Next 3Y42.28%
EBIT Next 5Y19.53%
FCF growth 1Y747.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.9%
OCF growth 3Y4.76%
OCF growth 5Y28.69%